Schiff Bases of Pioglitazone Provide Better Antidiabetic and Potent Antioxidant Effect in a Streptozotocin–Nicotinamide-Induced Diabetic Rodent Model

[Image: see text] Pioglitazone is a Food and Drug Administration-approved thiazolidinedione (TZD) derivative and peroxisome proliferator-activated receptor gamma (PPARγ) agonist and used for the treatment of diabetes mellitus (DM). However, this drug is still associated with many adverse effects. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Afzal, Hafiza Rabia, Khan, Najm ul Hassan, Sultana, Kishwar, Mobashar, Aisha, Lareb, Aqsa, Khan, Ayesha, Gull, Abrashim, Afzaal, Hasan, Khan, Muhammad Tariq, Rizwan, Muhammad, Imran, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893790/
https://www.ncbi.nlm.nih.gov/pubmed/33623853
http://dx.doi.org/10.1021/acsomega.0c06064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893790/
https://www.ncbi.nlm.nih.gov/pubmed/33623853
http://dx.doi.org/10.1021/acsomega.0c06064

Ejemplares similares